Lowy: “We Need to Continually Look at the Distribution of Funds That We Allocate to the Areas of Investment” April 17, 2015Vol.41 No.15
In Brief Robert Gentleman appointed vice president of computational biology at 23andMe Inc. April 03, 2015Vol.41 No.13
In Brief Lucille Adams-Campbell to Deliver Minorities in Cancer Research Lecture at AACR Annual Meeting April 03, 2015Vol.41 No.13
Drugs & Targets Intrexon Corporation and Merck Serono to collaborate on CAR-T cancer therapies April 03, 2015Vol.41 No.13
Drugs & Targets Merck and Syndax Pharmaceuticals to evaluate combination of Keytruda and entinostat April 03, 2015Vol.41 No.13
Drugs & Targets Eli Lilly and OncoMed Pharmaceuticals to evaluate combination of demcizumab and Alimta April 03, 2015Vol.41 No.13
Drugs & Targets MD Anderson Cancer Center and Astellas Pharma Inc. sign option agreement for AML research April 03, 2015Vol.41 No.13
Drugs & Targets FDA Approves Chelator Jadenu, an Oral Formulation of Exjade April 03, 2015Vol.41 No.13
Drugs & Targets FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer April 03, 2015Vol.41 No.13
